| - SMTL ID
- 3hwn.1
- Ligands
- Nalpha-[(3-tert-butyl-1-methyl-1H-pyrazol-5-yl)carbonyl]-N-[(2E)-2-iminoethyl]-3-{5-[(Z)-iminomethyl]-1,3,4-oxadiazol-2-yl}-L-phenylalaninamide
- Polypeptides
- Cathepsin L1
- Oligo-state
- monomer
|
| - SMTL ID
- 3hwn.2
- Ligands
- Nalpha-[(3-tert-butyl-1-methyl-1H-pyrazol-5-yl)carbonyl]-N-[(2E)-2-iminoethyl]-3-{5-[(Z)-iminomethyl]-1,3,4-oxadiazol-2-yl}-L-phenylalaninamide
- Polypeptides
- Cathepsin L1
- Oligo-state
- monomer
|
| - SMTL ID
- 3hwn.3
- Ligands
- Nalpha-[(3-tert-butyl-1-methyl-1H-pyrazol-5-yl)carbonyl]-N-[(2E)-2-iminoethyl]-3-{5-[(Z)-iminomethyl]-1,3,4-oxadiazol-2-yl}-L-phenylalaninamide
- Polypeptides
- Cathepsin L1
- Oligo-state
- monomer
|
| - SMTL ID
- 3hwn.4
- Ligands
- Nalpha-[(3-tert-butyl-1-methyl-1H-pyrazol-5-yl)carbonyl]-N-[(2E)-2-iminoethyl]-3-{5-[(Z)-iminomethyl]-1,3,4-oxadiazol-2-yl}-L-phenylalaninamide
- Polypeptides
- Cathepsin L1
- Oligo-state
- monomer
|